Utility of DNA Probing for Early Identification of M. tuberculosis (M.tb) as a Means for Cost Minimization for Isolation Precautions.

A. PHILLIPS*, J. DOWNEY, J.BURT, H. SIMPSON, B. MARSHALL, J. BRUNTON, J. CONLY.

Dept. of Microbiology, The Toronto Hospital, Toronto, Canada.

The use of DNA probing for the different for the differentiation of M.tb from mycobacteria other
than tuberculosis (MOTT) leads to earlier treatment and optimal use of isolation. The costs for isolation in our hospital for patients with acidfast bacilli in their sputum is as follows:

ITEM COST($) COST/DAY($) COST FOR 5d($)
Single room 175 175 875
Garbage bags 0.12/bag 0.24 1.20
Isolation gowns 0.37/lb 6.00 30
Procedure mask 6.77/box 6.77 33.85


A 14 mo. and 60 mo. epidemiologic survey of M.tb and MOTT in our hospital revealed that
37/188 (19.6%) submitted specimens/month were AFB+. There were a mean of 5 new M.tb and 12 MOTT isolates/month. With a ratio of pulmonary: non-pulmonary isolates of 2:1 and a prevalence survey revealing 4-6 in-patients requiring isolation in any given month, and operating costs of $2,048/annum for probing vs $2,132/annum for conventional identification (NAP) the cost saving for isolation for a 5d lead time for identification of M.tb range from $45-68,000/annum. We conclude that the use of DNA probing may substantially reduce isolation costs for pulmonary AFB disease.

Back to Posters and Abstracts